80 related articles for article (PubMed ID: 26545)
1. Phenytoin metabolism in the rat. Pharmacokinetic correlation between in vitro hepatic microsomal enzyme activity and in vivo elimination kinetics.
Collins JM; Blake DA; Egner PG
Drug Metab Dispos; 1978; 6(3):251-7. PubMed ID: 26545
[No Abstract] [Full Text] [Related]
2. Influence of pregnancy and folic acid on phenytoin metabolism by rat liver microsomes.
Blake DA; Collins JM; Miyasaki BC; Cohen F
Drug Metab Dispos; 1978; 6(3):246-50. PubMed ID: 26544
[TBL] [Abstract][Full Text] [Related]
3. The metabolism of phenytoin by isolated hepatocytes and hepatic microsomes from male rats.
Tsuru M; Erickson RR; Holtzman JL
J Pharmacol Exp Ther; 1982 Sep; 222(3):658-61. PubMed ID: 7108769
[TBL] [Abstract][Full Text] [Related]
4. Postnatal development of phenytoin metabolic activity in rat liver microsomes.
Blake DA; Cohen F; Miyasaki BC
Drug Metab Dispos; 1978; 6(3):240-5. PubMed ID: 26543
[No Abstract] [Full Text] [Related]
5. Sigmoidal kinetics of CYP3A substrates: an approach for scaling dextromethorphan metabolism in hepatic microsomes and isolated hepatocytes to predict in vivo clearance in rat.
Witherow LE; Houston JB
J Pharmacol Exp Ther; 1999 Jul; 290(1):58-65. PubMed ID: 10381760
[TBL] [Abstract][Full Text] [Related]
6. Genetic differences in phenytoin pharmacokinetics. In vivo clearance and in vitro metabolism among inbred strains of mice.
Atlas SA; Zweier JL; Nebert DW
Dev Pharmacol Ther; 1980; 1(5):281-304. PubMed ID: 7438974
[TBL] [Abstract][Full Text] [Related]
7. Interaction between phenytoin, 5-(p-hydroxyphenyl)-5-phenylhydantoin and valproate in the rat.
O'Leary TD; Sansom LN
J Pharmacol Exp Ther; 1981 Mar; 216(3):613-6. PubMed ID: 6782238
[TBL] [Abstract][Full Text] [Related]
8. Plasma protein binding and metabolic clearance of phenytoin in the rat.
Colburn WA; Gibaldi M
J Pharmacol Exp Ther; 1977 Dec; 203(3):500-6. PubMed ID: 925955
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and metabolism of a cysteinyl leukotriene-1 receptor antagonist from the heterocyclic chromanol series in rats: in vitro-in vivo correlation, gender-related differences, isoform identification, and comparison with metabolism in human hepatic tissue.
Kuperman AV; Kalgutkar AS; Marfat A; Chambers RJ; Liston TE
Drug Metab Dispos; 2001 Nov; 29(11):1403-9. PubMed ID: 11602515
[TBL] [Abstract][Full Text] [Related]
10. Study of the stereoselectivity of the para-hydroxylation of diphenylhydantoin by the rat liver microsomal cytochrome P-450-dependent enzymes [proceedings].
Cavalier R; Toussaint A; Cumps J
Arch Int Physiol Biochim; 1978 May; 86(2):411-3. PubMed ID: 81000
[No Abstract] [Full Text] [Related]
11. Effects of diazepam on the biliary excretion of diphenylhydantoin in the rat.
El-Hawari AM; Plaa GL
J Pharmacol Exp Ther; 1977 Apr; 201(1):14-25. PubMed ID: 850136
[TBL] [Abstract][Full Text] [Related]
12. Diphenylhydantoin metabolism by rat liver microsomes and some of the effects of drug or chemical pretreatment on diphenylhydantoin metabolism by rat liver microsomal preparations.
Kutt H; Fouts JR
J Pharmacol Exp Ther; 1971 Jan; 176(1):11-26. PubMed ID: 5569630
[No Abstract] [Full Text] [Related]
13. Persistent defects in the hepatic monooxygenase system of adult rats exposed, perinatally, to maternally administered phenytoin.
Shapiro BH; Lech GM; Bardales RM
J Pharmacol Exp Ther; 1986 Jul; 238(1):68-75. PubMed ID: 3723406
[TBL] [Abstract][Full Text] [Related]
14. Potential molecular targets mediating chemical teratogenesis: in vitro peroxidase-catalyzed phenytoin metabolism and oxidative damage to proteins and lipids in murine maternal hepatic microsomes and embryonic 9000g supernatant.
Liu L; Wells PG
Toxicol Appl Pharmacol; 1995 Sep; 134(1):71-80. PubMed ID: 7676459
[TBL] [Abstract][Full Text] [Related]
15. Phenytoin metabolic activation: role of cytochrome P-450, glutathione, age, and sex in rats and mice.
Roy D; Snodgrass WR
Res Commun Chem Pathol Pharmacol; 1988 Feb; 59(2):173-90. PubMed ID: 3358010
[TBL] [Abstract][Full Text] [Related]
16. Effects of liver congestion on hepatic drug metabolism in the rat.
Knodell RG; Farleigh RM; Steele NM; Bond JH
J Pharmacol Exp Ther; 1982 Apr; 221(1):52-7. PubMed ID: 7062291
[TBL] [Abstract][Full Text] [Related]
17. Biliary excretion of drugs: role of ligandin in newborn immaturity and in the action of microsomal enzyme inducers.
Klaassen CD
J Pharmacol Exp Ther; 1975 Nov; 195(2):311-9. PubMed ID: 1185600
[TBL] [Abstract][Full Text] [Related]
18. Nonspecific binding to microsomes: impact on scale-up of in vitro intrinsic clearance to hepatic clearance as assessed through examination of warfarin, imipramine, and propranolol.
Obach RS
Drug Metab Dispos; 1997 Dec; 25(12):1359-69. PubMed ID: 9394025
[TBL] [Abstract][Full Text] [Related]
19. Interactions between folate metabolism, phenytoin metabolism, and liver microsomal cytochrome P450.
Billings RE
Drug Nutr Interact; 1984; 3(1):21-32. PubMed ID: 6510238
[TBL] [Abstract][Full Text] [Related]
20. Decreases in phenytoin hydroxylation activities catalyzed by liver microsomal cytochrome P450 enzymes in phenytoin-treated rats.
Yamazaki H; Komatsu T; Takemoto K; Saeki M; Minami Y; Kawaguchi Y; Shimada N; Nakajima M; Yokoi T
Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):427-34. PubMed ID: 11259327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
